- Title
- Selective targeting of alpha 4 beta 1 integrin attenuates murine graft versus host disease
- Creators - without role
- Bader Alahmari - Washington University in St. LouisMatthew L. Cooper - Supreme Council Of HealthKiran Vij - Washington University in St. LouisJulie Ritchey - Washington University in St. LouisPeter Ruminski - Washington University in St. LouisFeng Gao - Washington University in St. LouisJaebok Choi - Washington University in St. LouisJohn F. DiPersio - Washington University in St. Louis
- Publication Details
- Leukemia, Vol.34(11), pp.3100-3104
- Publisher
- Springer Nature
- Number of pages
- 5
- Grant note
- P30 CA091842 / National Cancer Institute Cancer Center Support Grant; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Rays of Hope St. Baldrick's Research Grant (St. Baldrick's Foundation) Alvin J. Siteman Cancer Center Siteman Investment Program P50 CA171963-01 / Washington University SPORE-CDP Foundation for Barnes-Jewish Hospital Cancer Frontier Fund The Amy Strelzer Manasevit Research Program (Be The Match Foundation and National Marrow Donor Program) Barnard Trust Bryan Thomas Campbell Foundation P50 CA171963-01; P50 CA94056-09; R35 CA210084-01 / National Cancer Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
- Identifiers
- 9920989608331
- Academic Unit
- King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
- Language
- English
- Resource Type
- Journal article
Journal article
Selective targeting of alpha 4 beta 1 integrin attenuates murine graft versus host disease
Leukemia, Vol.34(11), pp.3100-3104
01/11/2020
PMID: 32152466
Metrics
1 Record Views